Pharmaceutical Executive April 1, 2025
LillyDirect will help provide services to millions of patients who have yet to be formally diagnosed with the disease.
LillyDirect will now offer Alzheimer’s care.
Eli Lilly announced the addition to its digital healthcare platform, which will be able to provide both in-person and telehealth services. According to Lilly, the majority of people in the US living with Alzheimer’s have not been formally diagnosed, yet they still require access to care and services. The problems with getting formally diagnosed are expected to get worse in the coming year.
In a press release, Eli Lilly’s chief medical officer David Hyman, MD, said, “We know that early diagnosis and care can make a big difference for people living with Alzheimer’s disease. By...